Skip to content

Author

Shi-Long Mao

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Mechanisms of resistance to immune checkpoint inhibitors in renal cell carcinoma and novel treatment strategies

In recent years, immune checkpoint inhibitors (ICIs), such as nivolumab, ipilimumab, pembrolizumab, and atezolizumab have substantially improved the prognosis of patients with advanced renal cell carcinoma. These agents have greatly changed the management of advanced renal cell carcinoma, shifting the treatment paradig...

Li Chen, Jie Cheng, Shi-Long Mao · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.